{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:29:30Z","timestamp":1782473370651,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","award":["10332"],"award-info":[{"award-number":["10332"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["1130271"],"award-info":[{"award-number":["1130271"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","award":["PFB-16"],"award-info":[{"award-number":["PFB-16"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neuropharm.2016.09.028","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:21:44Z","timestamp":1475281304000},"page":"110-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"PA","title":["Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"113","author":[{"given":"Daniela","family":"Elgueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andro","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Celorrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Rojo-Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-9806","authenticated-orcid":false,"given":"Rodrigo","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.09.028_bib1","first-page":"13","article-title":"CD4+ T cells mediate cytotoxicity in neurodegenerative diseases","volume":"119","author":"Appel","year":"2009","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib2","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneumeth.2013.07.017","article-title":"Immunomagnetic enrichment and flow cytometric characterization of mouse microglia","volume":"219","author":"Bedi","year":"2013","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.07.013","article-title":"Dopamine by itself activates either D2, D3 or D1\/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both","volume":"169","author":"Besser","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib5","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nature09788","article-title":"Caspase signalling controls microglia activation and neurotoxicity","volume":"472","author":"Burguillos","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/glia.20117","article-title":"Differential activation of astrocytes by innate and adaptive immune stimuli","volume":"49","author":"Carpentier","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2202-14-76","article-title":"Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib10","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1172\/JCI67569","article-title":"Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure","volume":"123","author":"Cutando","year":"2013","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson's disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20091419","article-title":"Regulation of learning and memory by meningeal immunity: a key role for IL-4","volume":"207","author":"Derecki","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1460-9568.1994.tb00329.x","article-title":"Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens","volume":"6","author":"Diaz","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","article-title":"Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain","volume":"65","author":"Diaz","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/glia.20897","article-title":"Axonal plasticity elicits long-term changes in oligodendroglia and myelinated fibers","volume":"58","author":"Drojdahl","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/syn.20977","article-title":"Acetylcholine alpha7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex","volume":"65","author":"Duffy","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","article-title":"Dopamine and noradrenaline control distinct functions in rodent microglial cells","volume":"29","author":"Farber","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","article-title":"Astrocytes are active players in cerebral innate immunity","volume":"28","author":"Farina","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib19","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fernandez-Suarez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib20","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jalz.2013.12.005","article-title":"Exenatide as a potential treatment for patients with Parkinson's disease: first steps into the clinic","volume":"10","author":"Foltynie","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2015.05.003","article-title":"Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production","volume":"284","author":"Franz","year":"2015","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","article-title":"Regulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells","volume":"10","author":"Gonzalez","year":"2015","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib24","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","article-title":"Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease","volume":"190","author":"Gonzalez","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonzalez","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonzalez","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib28","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib30","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/jcbfm.2015.128","article-title":"De novo expression of dopamine D2 receptors on microglia after stroke","volume":"35","author":"Huck","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1096\/fj.04-1652fje","article-title":"Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells","volume":"18","author":"Ilani","year":"2004","journal-title":"Faseb J."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4522(02)00067-2","article-title":"Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors","volume":"112","author":"Joseph","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7007-2-22","article-title":"Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor","volume":"2","author":"Joyce","year":"2004","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease","volume":"202","author":"Kim","year":"2009","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2006.07.120","article-title":"The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes","volume":"1116","author":"Kuno","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2818.1998.00365.x","article-title":"Global spatial sampling with isotropic virtual planes: estimators of length density and total length in thick, arbitrarily orientated sections","volume":"191","author":"Larsen","year":"1998","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib38","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib39","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib40","doi-asserted-by":"crossref","first-page":"E3432","DOI":"10.1073\/pnas.1408780111","article-title":"Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"Lucin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib42","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s10620-006-9168-3","article-title":"Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment","volume":"51","author":"Magro","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib43","first-page":"749","article-title":"Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors","volume":"43","author":"Malmberg","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/jpet.109.165084","article-title":"Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse","volume":"333","author":"Mason","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib45","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.neurobiolaging.2008.01.001","article-title":"Microglial responses to dopamine in a cell culture model of Parkinson's disease","volume":"30","author":"Mastroeni","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2011.05.031","article-title":"Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium","volume":"307","author":"McGuire","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(95)90013-6","article-title":"Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors","volume":"290","author":"Mierau","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2004.09.014","article-title":"Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia","volume":"1029","author":"Miyazaki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.158.2.614","article-title":"IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells","volume":"158","author":"Nikcevich","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","volume":"3","author":"Noelker","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2014.00117","article-title":"The dopaminergic system in autoimmune diseases","volume":"5","author":"Pacheco","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2007.01.003","article-title":"Role of glutamate on T-cell mediated immunity","volume":"185","author":"Pacheco","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib53","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1871530311313020007","article-title":"Modulation of T-cell mediated immunity by dopamine receptor d5","volume":"13","author":"Prado","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib56","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib57","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib58","first-page":"129605","article-title":"An NR2B-dependent decrease in the expression of trkB receptors precedes the disappearance of dopaminergic cells in substantia Nigra in a rat model of presymptomatic Parkinson's disease","volume":"2012","author":"Riquelme","year":"2012","journal-title":"Park. Dis."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib59","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.02.008","article-title":"The relation between alpha-synuclein and microglia in Parkinson's disease: recent developments","volume":"302","author":"Sanchez-Guajardo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0166-2236(03)00126-7","article-title":"Protective autoimmunity against the enemy within: fighting glutamate toxicity","volume":"26","author":"Schwartz","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature11748","article-title":"Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin","volume":"494","author":"Shao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0074-7742(08)60573-5","article-title":"Molecular neurobiology of dopaminergic receptors","volume":"35","author":"Sibley","year":"1993","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0197-0186(93)90050-F","article-title":"New insights into dopamine receptors in the central nervous system","volume":"22","author":"Strange","year":"1993","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib66","first-page":"119","article-title":"Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.3479","article-title":"Dopamine mediates vagal modulation of the immune system by electroacupuncture","volume":"20","author":"Torres-Rosas","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib69","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/jm030614p","article-title":"Dopamine D1\/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1\/D5 antagonists","volume":"48","author":"Wu","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbr.2013.01.019","article-title":"Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice","volume":"243","author":"Xing","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2016.09.028_bib72","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.neuropharm.2016.09.028_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","article-title":"TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition","volume":"1034","author":"Zou","year":"2005","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T09:02:19Z","timestamp":1692522139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816304385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":73,"alternative-id":["S0028390816304385"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.028","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}